References
- Reilly MM, Murphy SM, Laurá M. Charcot–Marie–Tooth disease. J. Peripher. Nerv. Syst. 16(1), 1–14 (2011).
- Azhary H, Farooq MU, Bhanushali M, Majid A, Kassab MY. Peripheral neuropathy: differential diagnosis and management. Am. Fam. Physician 81(7), 887–892 (2010).
- Patzkó A, Shy ME. Update on Charcot–Marie–Tooth disease. Curr. Neurol. Neurosci. Rep. 11(1), 78–88 (2011).
- Lee SM, Chin LS, Li L. Protein misfolding and clearance in demyelinating peripheral neuropathies: therapeutic implications. Commun. Integr. Biol. 5(1), 107–110 (2012).
- Olzmann JA, Li L, Chin LS. Aggresome formation and neurodegenerative diseases: therapeutic implications. Curr. Med. Chem. 15(1), 47–60 (2008).
- Weimer LH, Podwall D. Medication-induced exacerbation of neuropathy in Charcot Marie Tooth disease. J. Neurol. Sci. 242(1–2), 47–54 (2006).
- Pareyson D, Marchesi C. Diagnosis, natural history, and management of Charcot–Marie–Tooth disease. Lancet Neurol. 8(7), 654–667 (2009).
- Rangaraju S, Verrier JD, Madorsky I, Nicks J, Dunn WA Jr, Notterpek L. Rapamycin activates autophagy and improves myelination in explant cultures from neuropathic mice. J. Neurosci. 30(34), 11388–11397 (2010).
- Goebbels S, Oltrogge JH, Wolfer S et al. Genetic disruption of Pten in a novel mouse model of tomaculous neuropathy. EMBO Mol. Med. 4(6), 486–499 (2012).
- Macklin WB. The myelin brake: when enough is enough. Sci. Signal. 3(140), pe32 (2010).
- Sander S, Ouvrier RA, McLeod JG, Nicholson GA, Pollard JD. Clinical syndromes associated with tomacula or myelin swellings in sural nerve biopsies. J. Neurol. Neurosurg. Psychiatr. 68(4), 483–488 (2000).
- Quattrone A, Gambardella A, Bono F et al. Autosomal recessive hereditary motor and sensory neuropathy with focally folded myelin sheaths: clinical, electrophysiologic, and genetic aspects of a large family. Neurology 46(5), 1318–1324 (1996).
- Berger P, Tersar K, Ballmer-Hofer K, Suter U. The CMT4B disease-causing proteins MTMR2 and MTMR13/SBF2 regulate AKT signalling. J. Cell. Mol. Med. 15(2), 307–315 (2011).
- Lee SM, Olzmann JA, Chin LS, Li L. Mutations associated with Charcot–Marie–Tooth disease cause SIMPLE protein mislocalization and degradation by the proteasome and aggresome–autophagy pathways. J. Cell. Sci. 124(Pt 19), 3319–3331 (2011).
- Arnaud E, Zenker J, de Preux Charles AS et al. SH3TC2/KIAA1985 protein is required for proper myelination and the integrity of the node of Ranvier in the peripheral nervous system. Proc. Natl Acad. Sci. USA 106(41), 17528–17533 (2009).
- Stendel C, Roos A, Kleine H et al. SH3TC2, a protein mutant in Charcot–Marie–Tooth neuropathy, links peripheral nerve myelination to endosomal recycling. Brain 133(Pt 8), 2462–2474 (2010).
- Tapinos N, Ohnishi M, Rambukkana A. ErbB2 receptor tyrosine kinase signaling mediates early demyelination induced by leprosy bacilli. Nat. Med. 12(8), 961–966 (2006).
- Jang SW, Liu X, Yepes M et al. A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone. Proc. Natl Acad. Sci. USA 107(6), 2687–2692 (2010).
- Makoukji J, Belle M, Meffre D et al. Lithium enhances remyelination of peripheral nerves. Proc. Natl Acad. Sci. USA 109(10), 3973–3978 (2012).